Xu Y - Search Results

1

Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis.

Kaufman HL, Schwartz LH, William WN Jr, Sznol M, Fahrbach K, Xu Y, Masson E, Vergara-Silva A. Kaufman HL, et al. Among authors: xu y. J Cancer Res Clin Oncol. 2018 Nov;144(11):2245-2261. doi: 10.1007/s00432-018-2738-x. Epub 2018 Aug 21. J Cancer Res Clin Oncol. 2018. PMID: 30132118 Review.

2

Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis.

Checchia PA, Nalysnyk L, Fernandes AW, Mahadevia PJ, Xu Y, Fahrbach K, Welliver RC Sr. Checchia PA, et al. Among authors: xu y. Pediatr Crit Care Med. 2011 Sep;12(5):580-8. doi: 10.1097/PCC.0b013e3182070990. Pediatr Crit Care Med. 2011. PMID: 21200358 Review.

3

Systematic literature review of clinical trials evaluating pharmacotherapy for overactive bladder in elderly patients: An assessment of trial quality.

Kistler KD, Xu Y, Zou KH, Ntanios F, Chapman DS, Luo X. Kistler KD, et al. Among authors: xu y. Neurourol Urodyn. 2018 Jan;37(1):54-66. doi: 10.1002/nau.23309. Epub 2017 Aug 1. Neurourol Urodyn. 2018. PMID: 28763112

4

Front-line treatment of patients with chronic lymphocytic leukemia: a systematic review and network meta-analysis.

Xu Y, Fahrbach K, Dorman E, Baculea S, Côté S, Sanden SV, Diels J. Xu Y, et al. J Comp Eff Res. 2018 May;7(5):421-441. doi: 10.2217/cer-2017-0086. Epub 2017 Dec 6. J Comp Eff Res. 2018. PMID: 29210593 Free article.

5

A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis.

Dimopoulos MA, Kaufman JL, White D, Cook G, Rizzo M, Xu Y, Fahrbach K, Gaudig M, Slavcev M, Dearden L, Lam A. Dimopoulos MA, et al. Among authors: xu y. Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):163-173.e6. doi: 10.1016/j.clml.2017.12.011. Epub 2018 Jan 5. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29456035 Free article.

6

A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis.

Weisel K, Sonneveld P, Spencer A, Beksac M, Rizzo M, Xu Y, Fahrbach K, Gaudig M, Slavcev M, Dearden L, Lam A. Weisel K, et al. Among authors: xu y. Leuk Lymphoma. 2019 Jan;60(1):151-162. doi: 10.1080/10428194.2018.1466392. Epub 2018 Nov 8. Leuk Lymphoma. 2019. PMID: 30407092

7

A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia.

Ashaye AO, Khankhel Z, Xu Y, Fahrbach K, Mokgokong R, Orme ME, Lang K, Cappelleri JC, Mamolo C. Ashaye AO, et al. Among authors: xu y. Future Oncol. 2019 Feb;15(6):663-681. doi: 10.2217/fon-2018-0512. Epub 2018 Nov 19. Future Oncol. 2019. PMID: 30450960 Free article.

8

Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.

Sorensen S, Wildgust M, Sengupta N, Trambitas C, Diels J, van Sanden S, Xu Y, Dorman E. Sorensen S, et al. Among authors: xu y. Clin Ther. 2017 Jan;39(1):178-189.e5. doi: 10.1016/j.clinthera.2016.12.001. Epub 2017 Jan 3. Clin Ther. 2017. PMID: 28062113 Review.

9

Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.

Feliciano JL, McLoone D, Xu Y, Quek RGW, Kuznik A, Pouliot JF, Gullo G, Rietschel P, Guyot P, Konidaris G, Chan K, Keeping S, Wilson FR, Freemantle N. Feliciano JL, et al. Among authors: xu y. Front Oncol. 2023 Apr 4;12:1081729. doi: 10.3389/fonc.2022.1081729. eCollection 2022. Front Oncol. 2023. PMID: 37082098 Free PMC article.

10

Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.

Keeping S, Xu Y, Chen CI, Cope S, Mojebi A, Kuznik A, Konidaris G, Ayers D, Sasane M, Allen R, Huynh TM, Popoff E, Freeman M, Andria ML, Fury MG, Singh K, Stockfleth E, Challapalli A, Schmults CD. Keeping S, et al. Among authors: xu y. Future Oncol. 2021 Feb;17(5):611-627. doi: 10.2217/fon-2020-0823. Epub 2020 Oct 14. Future Oncol. 2021. PMID: 33052055 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,250 results

Search Page